← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2010Last known activity
Dec 15, 2025
Acquired by Eli Lilly on Jan 1, 1990
Timeline
1990s
- Jan 1, 1990
Eli Lilly— Acquired By
2000s
- Jun 1, 2006
IASO Pharma Inc.— Founded
Drugs by trial phase (19 distinct, 19 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Indications
Recent trials (20)
- NCT07309900CollaboratorPhase 1Dec 15, 2025
- NCT07109986Lead sponsorPhase 1Aug 31, 2025
- NCT07055724Lead sponsorPhase 2Jul 31, 2025
- NCT06902844CollaboratorN/AApr 5, 2025
- NCT06743503Lead sponsorPhase 1Dec 31, 2024
- NCT06534021Lead sponsorPhase 1Aug 1, 2024
- NCT06464991Lead sponsorPhase 3Mar 27, 2024
- NCT05698303Study directorPhase 1May 8, 2023
- NCT05698303Lead sponsorPhase 1May 8, 2023
- NCT05759793Lead sponsorPhase 1Mar 30, 2023
- NCT05181501Lead sponsorPhase 1Apr 30, 2022
- NCT05219721CollaboratorPhase 1Mar 17, 2022
- NCT05201118CollaboratorPhase 1Jan 1, 2022
- NCT05166070CollaboratorEarly Phase 1Jan 1, 2022
- NCT05141253CollaboratorEarly Phase 1Dec 1, 2021
Details
- Founded
- San Diego, CA, US Jun 1, 2006
- Last known activity
- Dec 15, 2025